Susquehanna International Group’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Buy
+62,500
New +$114K ﹤0.01% 12314
2024
Q4
– Sell
-78,800
Closed -$151K – 12999
2024
Q3
$151K Sell
78,800
-124,700
-61% -$283K ﹤0.01% 10734
2024
Q2
$501K Buy
+203,500
New +$546K ﹤0.01% 8261
2023
Q2
– Sell
-11,300
Closed -$128K – 12908
2023
Q1
$128K Buy
+11,300
New +$120K ﹤0.01% 11072

Other funds holding PROK

Susquehanna International Group's PROK Position: Q2 2026 in Review

Susquehanna International Group increased its ProKidney (PROK) stake by 24% in Q2 2026, buying an estimated $88.6K and bringing the position to 252,906 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #9860.

Susquehanna International Group first reported a position in PROK in Q2 2023 and has held it in 10 quarters since. The position peaked at $893K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Susquehanna International Group held 252,906 shares of ProKidney worth $516K as of Q2 2026.
  • Susquehanna International Group bought 48,418 ProKidney shares in Q2 2026, an estimated $88.6K.
  • ProKidney made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #9860 holding.
  • Susquehanna International Group first reported a position in ProKidney in Q2 2023 and has held it in 10 quarters since.
  • Susquehanna International Group's ProKidney position peaked at $893K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.